7QV-30322-18599
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 601 / IL
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Hot flush — Feeling: Fair · Site: Pain · Headache, Muscle or body achesFree text: Hot flash x 2, PVCsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-21
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-11-29
Dose 3 — Pfizer-BioNTech
- 2022-01-13
-
2022-06-01
Survey response — 6 months, dose 3MedDRA: Cough, Pre-existing disease, Rhinorrhoea, Ventricular extrasystoles, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Allergies, PVCs, cough, runny nose, wheezingMedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-11-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-01 | Successful 2022-06-02 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Hot flash x 2, PVCs
Release 11 — 6 months, dose 3
Symptoms: Allergies, PVCs, cough, runny nose, wheezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Ventricular extrasystoles | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release